金黃色葡萄球菌與抗生素的聖戰

[pharmawind (Compulsive Disorder P't)]

金黃色葡萄球菌與抗生素的聖戰 (The War of the S. aureus & Antibiotics)

圖文好讀版：http://pharmawind.pixnet.net/blog/post/36066957

    金黃色葡萄球菌 (Staphylococcus aureus, S. aureus) 對人類來說是一個重要的
病原體。從歷史的角度來看，S. aureus 的侵入性感染總是造成很高的死亡率。
　　Staphylococcus aureus is an important human pathogen. Historically,
invasive infections have been associated with very high mortality rates.

　　

　　在磺胺類藥物還沒問世的1933-1936年代 (pre-sulfonamide period)，感染
S. aureus 所造成之菌血症病人的死亡率超過四分之三 (median 79%, range 56-89%)
(Arch Intern Med 1939; 63:1068–1083)。1937-1941年，因將磺胺藥導入治療而讓死
亡率降至 40% (Arch Intern Med 1941; 67:25–35)。
　　During the pre-sulfonamide period, 1933–1936, over three-quarters
(median 79%, range 56–89%) of patients with bacteraemic S. aureus infection
died [1]. The introduction of the sulfonamide agents, 1937–1941, reduced
these high mortality rates to 40% [2]. 


　　Penicillin 在 1942-1947 年以橫空出世之姿，將 S. aureus 菌血症感染之死亡率
將至 28%；然而，S. aureus 也在短期內強勢反擊，並在 1948-1953 將死亡率再度提升
至 45-50% (Arch Intern Med 1954; 94:167–196)。
　　The introduction of penicillin, 1942–1947, reduced the S. aureus
bacteraemia death rate to 28%; however, the rise of penicillin resistance
shortly thereafter, 1948–1953, was associated with higher mortalities of the
order of 45–50% [3]. 


　　1962 年 methicillin 殺出救援，成功地在這場戰爭中幫助抗生素陣營重拾優勢，
並將死亡率降至 25%。然而，俗諺有云：「道高一尺，魔高一丈」。幾乎就在 methi-
cillin 救援的同時，S. aureus 也進化成更兇殘的 methicillin-resistant S. aureus
(MRSA)，在死亡率表現方面，即便將許多共伴因素納入分析後仍可發現，MRSA 特種部
隊比 methicillin-susceptible S. aureus (MSSA) 傳統部隊還要十惡不赦 (OR 1.93,
95% CI 1.54–2.42, P<0.001) (Clin Infect Dis 2003; 36:53–59)。
　　After the introduction of methicillin in 1962, the mortality rates
decreased again to approximately 25% [52]. Almost as soon as methicillin was
introduced, MRSA was being reported [53]. Patients with MRSA bloodstream
infections have a greater mortality risk than those with methicillin-
susceptible S. aureus (MSSA) bacteraemia (OR 1.93, 95% CI 1.54–2.42,
P<0.001), even accounting for confounding variables such as the presence or
absence of central venous access devices, endocarditis, bacteraemia during
an outbreak, and severity of underlying illness [4]. 


　　雖然時至今日，萬古神兵 - vancomycin 仍然是對 MRSA 的首選武器，但 MRSA 對
vancomycin 的敏感性日益降低已經成為大家高度關注的問題，MRSA 再一次超進化成
vancomycin-intermediate S. aureus (VISA) 與 vancomycin-resistant S. aureus
(VRSA)，也將死亡率推向另一個高峰 (63%) (Clin Infect Dis 2003; 36:429–439)。
　　More recently, concern has been expressed regarding the identification of
MRSA strains with reduced susceptibility to vancomycin,
vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus,
that have been associated with higher bacteraemia-related mortality rates
(63%) [5].
　

    隨著超世代神兵陸續的誕生，以及 S. aureus 不斷的進化，這場以人體為戰場的
兵燹征戎，將永無停戰的一天。

超世代神兵 - Linezolid
超世代神兵 - Quinupristim/Dalfopristin
超世代神兵 - Tigecycline
超世代神兵 - Daptomycin
超世代神兵 - Telavancin
超世代神兵 - Ceftaroline


Reference:

[1] Mendell TH. Staphylococcal septicemia: a review of thirty-five cases,
    with six recoveries, twenty-nine deaths, and sixteen autopsies. Arch
    Intern Med 1939; 63:1068–1083.
[2] Spink WW, Hansen AE, Paine JR. Staphylococcal bacteremia, treatment
    with sulfapyridine and sulfathiazole. Arch Intern Med 1941; 67:25–35
[3] Spink WW. Staphylococcal infections and the problem of antibiotic-
    resistant Staphylococci. Arch Intern Med 1954; 94:167–196.
[4] Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality
    associated with methicillin-resistant and methicillin-susceptible
    Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;
    36:53–59.
[5] Fridkin SK, Hageman J, McDougal LK, et al. Epidemiological and micro-
    biological characterization of infections caused by Staphylococcus
    aureus with reduced susceptibility to vancomycin, United States,
    1997–2001. Clin Infect Dis 2003; 36:429–439.


--
            隔壁的   在班上出風頭  會打籃球   有汽車的人 有錢有車有房
            大哥哥      的男生    又帥的學長                的主管       女生
 女生 ─┬─────┼─────┼─────┼─────┼─────→ 是善變的
  ♀    喜  國小時      國中時      高中時      大學時      社會時
  ♂    歡                                                              男生
 男生 ─┴──年──┼──輕──┼──的──┼──正──┼──妹──→ 是專一的

--
※ 發信站: 批踢踢實業坊(ptt.cc) 
◆ From: 101.12.248.82
推 lavenderess:好文！
推 sdbb:快推，以免人家說我看不懂
推 DM1984:有看有推XD
→ pharmawind:我寫的很口語很搞笑 看不懂請別見怪XD
推 Abyss:強者
推 BestYoung:文筆不錯啊，應該醫藥相關人員都看得津津有味吧! @_@
推 stvene:數碼寶貝化 XD
推 HTTRE:好文必推ㄧㄧ
推 MikeFreeway:我笑了，好文推XDy
推 leafleft:推~期待其他系列XD
推 MikeFreeway:唉....開始脫節了啊.....Orz
推 virgil010030:好文值得按1，淺顯易懂
推 lovelyours:我笑了 學長推XD
推 gysample:好文